Logo

American Heart Association

  2
  0


Final ID:

Perspectives from a Clinical Trialist

  • Menon, Bijoy  ( FOOTHILLS HOSPITAL , Calgary , Alberta , Canada )
  • Author Disclosures:
    Bijoy Menon: DO have relevant financial relationships ; Individual Stocks/Stock Options:Circle CVI:Active (exists now) ; Advisor:Boehringer Ingelheim:Past (completed)
Meeting Info:
Session Info:

Stroke in the Lab World: Investigational Targets in Ischemic Stroke: Ready, Set, Translate!

Tuesday, 02/04/2025 , 09:00AM - 05:00PM

Pre-Con Symposium – Stroke in the Lab World

More abstracts on this topic:
Immunomodulation -II

Chang Che-feng

Neuromodulation

Arsava Ethem

More abstracts from these authors:
Prevalence, Characteristics, and Recurrent Event Risk of Cerebrovascular Fibromuscular Dysplasia in Patients with Ischemic Stroke or Transient Ischemic Attack– A Population-level Study

Kathuveetil Arun, Ray Sucharitha, Hewawasan Yovan, Peters Steven, Menon Bijoy, Singh Nishita, Ganesh Aravind

Summary of Tenecteplase data 0-24h

Coutts Shelagh, Menon Bijoy, Xiong Yunyun

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)